The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer

• Main Authors: Sarah Sharman Moser (Author), Frank Tanser (Author), Nava Siegelmann-Danieli (Author), Lior Apter (Author), Gabriel Chodick (Author), Josie Solomon (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Key points Our study found that there are substantial differences in time to reimbursement of pembrolizumab for the same conditions in different countries, with NICE and The National Advisory Committee for the Basket of Health Services in Israel approving one condition at the same time, Israel appro...